Bosun Asset Management’s Abivax ABVX Stock Holding History

Bosun Asset Management’s Portfolio ABVX Stock Details ABVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-34,750	Closed	-$459K	–	186
2024 Q2	$459K	Buy	+34,750	New	+$497K	0.27%	93

Other funds holding ABVX

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Bosun Asset Management's ABVX Position: Q3 2024 in Review

Bosun Asset Management sold out of Abivax (ABVX) in Q3 2024, closing a stake of 34,750 shares — an estimated $459K sold.

Bosun Asset Management first reported a position in ABVX in Q2 2024 and held it in 1 quarter. The position peaked at $459K in Q2 2024. 40 funds tracked by Wall St. Rank hold ABVX as of Q3 2024.

Bosun Asset Management reported no remaining Abivax position as of Q3 2024 after selling out during the quarter.
Bosun Asset Management sold 34,750 Abivax shares in Q3 2024, an estimated $459K.
Bosun Asset Management first reported a position in Abivax in Q2 2024 and held it in 1 quarter.
Bosun Asset Management's Abivax position peaked at $459K in Q2 2024.
40 funds tracked by Wall St. Rank held Abivax as of Q3 2024.

Based on Bosun Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.